chartexchange

SRTS
Sensus Healthcare, Inc
stockNASDAQ

At CloseNov 18, 2026 3:59:22 PM EST
2.30USD+1.549%(+0.04)77,187
Pre-marketNov 18, 2026 9:09:30 AM EST
2.2603USD+0.013%(+0.0003)
After-hoursNov 18, 2026 4:00:30 PM EST
2.30USD+0.218%(+0.01)
Loading…
Loading…
Healthcare
Medical Devices
CEO
Joseph Sardano
HQ
Boca Raton, FL, USA
Previous Close
$2.26
Beta
1.19
52-Week High
$5.49 2026-01-13
52-Week Low
$2.14 2026-11-17
SMA 50
$2.94
SMA 200
$3.41
Avg. Vol 10D
170,608
Avg. Vol 30D
396,702
Avg. Vol 90D
152,182
Relative Vol
0.19
13.39M
0.8400%
1,200,000
346
SRTS Profile

sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.

SRTS Performance
PeriodPriceDateChangeBeta
1W3.412026-11-11-32.99%-11.477
1M2.762026-10-19-17.21%2.174
3M3.002026-08-18-23.83%1.651
6M3.472026-05-18-34.15%1.013
1Y4.042025-11-18-43.44%1.185
2Y8.412024-11-18-72.83%—
5Y5.522021-11-18-58.60%0.970
SRTS Stock Summary

Sensus Healthcare, Inc (NASDAQ:SRTS) stock price today is $2.29, and today's volume is 77,189. SRTS is up 1.106% today. The 30 day average volume is 396,702. SRTS market cap is $37.62M with 16.46M shares outstanding.